Alexander Mallios (Paris, France) and Andrew Holden (Auckland, New Zealand; one of the co-chairs of the Charing Cross [CX] Symposium) share their views on the first and only consistently positive randomised controlled trial results that are “unequivocally” in favour of drug-coated balloon (DCB) therapy for arteriovenous (AV) access patients. They comment on whether DCBs … Continue reading IN.PACT AV Access five-year results strengthen physicians’ conviction on applying DCB therapy